|
ATN1 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.64890000001294E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.35690000000211E-05 |
| Normal-vs-Stage2 |
4.482200E-02 |
| Normal-vs-Stage3 |
1.47589999999198E-07 |
| Normal-vs-Stage4 |
1.699500E-03 |
| Stage1-vs-Stage2 |
2.761800E-01 |
| Stage1-vs-Stage3 |
1.658380E-02 |
| Stage1-vs-Stage4 |
8.619000E-01 |
| Stage2-vs-Stage3 |
1.139550E-02 |
| Stage2-vs-Stage4 |
3.399200E-01 |
| Stage3-vs-Stage4 |
1.260810E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69100000002587E-06 |
| Normal-vs-AfricanAmerican |
2.332600E-01 |
| Normal-vs-Asian |
5.292200E-02 |
| Caucasian-vs-AfricanAmerican |
7.047600E-02 |
| Caucasian-vs-Asian |
6.397700E-02 |
| AfricanAmerican-vs-Asian |
7.275400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.154190E-04 |
| Normal-vs-Female |
4.4268000000125E-06 |
| Male-vs-Female |
9.655000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.81150000000607E-05 |
| Normal-vs-Age(41-60Yrs) |
2.818700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.10449999999973E-05 |
| Normal-vs-Age(81-100Yrs) |
1.561200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.306200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.099400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.718420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.891800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.868100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.040800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.10489999997021E-07 |
| Classical-VS-Follicular |
8.127000E-01 |
| Classical-VS-Other |
8.829000E-01 |
| Classical-VS-Normal |
8.08389999999992E-05 |
| Tall-VS-Follicular |
1.411480E-04 |
| Tall-VS-Other |
1.329530E-02 |
| Tall-VS-Normal |
1.87000004370219E-09 |
| Follicular-VS-Other |
8.450000E-01 |
| Follicular-VS-Normal |
2.240600E-03 |
| Other-VS-Normal |
2.167400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.167200E-04 |
| Normal-vs-N1 |
2.255600E-03 |
| N0-vs-N1 |
8.764800E-01 |
|
|
